Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Aug 8;8(8):CD012077.
doi: 10.1002/14651858.CD012077.pub2.

Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews

Emily Shepherd  1 , Rehana A Salam, Philippa Middleton, Maria Makrides, Sarah McIntyre, Nadia Badawi, Caroline A Crowther
Affiliations
Meta-Analysis

Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews

Emily Shepherd et al. Cochrane Database Syst Rev. .

Abstract

Background: Cerebral palsy is an umbrella term encompassing disorders of movement and posture, attributed to non-progressive disturbances occurring in the developing fetal or infant brain. As there are diverse risk factors and causes, no one strategy will prevent all cerebral palsy. Therefore, there is a need to systematically consider all potentially relevant interventions for their contribution to prevention.

Objectives: To summarise the evidence from Cochrane reviews regarding the effects of antenatal and intrapartum interventions for preventing cerebral palsy.

Methods: We searched the Cochrane Database of Systematic Reviews on 7 August 2016, for reviews of antenatal or intrapartum interventions reporting on cerebral palsy. Two authors assessed reviews for inclusion, extracted data, assessed review quality, using AMSTAR and ROBIS, and quality of the evidence, using the GRADE approach. We organised reviews by topic, and summarised findings in text and tables. We categorised interventions as effective (high-quality evidence of effectiveness); possibly effective (moderate-quality evidence of effectiveness); ineffective (high-quality evidence of harm or of lack of effectiveness); probably ineffective (moderate-quality evidence of harm or of lack of effectiveness); and no conclusions possible (low- to very low-quality evidence).

Main results: We included 15 Cochrane reviews. A further 62 reviews pre-specified the outcome cerebral palsy in their methods, but none of the included randomised controlled trials (RCTs) reported this outcome. The included reviews were high quality and at low risk of bias. They included 279 RCTs; data for cerebral palsy were available from 27 (10%) RCTs, involving 32,490 children. They considered interventions for: treating mild to moderate hypertension (two) and pre-eclampsia (two); diagnosing and preventing fetal compromise in labour (one); preventing preterm birth (four); preterm fetal maturation or neuroprotection (five); and managing preterm fetal compromise (one). Quality of evidence ranged from very low to high. Effective interventions: high-quality evidence of effectiveness There was a reduction in cerebral palsy in children born to women at risk of preterm birth who received magnesium sulphate for neuroprotection of the fetus compared with placebo (risk ratio (RR) 0.68, 95% confidence interval (CI) 0.54 to 0.87; five RCTs; 6145 children). Probably ineffective interventions: moderate-quality evidence of harm There was an increase in cerebral palsy in children born to mothers in preterm labour with intact membranes who received any prophylactic antibiotics versus no antibiotics (RR 1.82, 95% CI 0.99 to 3.34; one RCT; 3173 children). There was an increase in cerebral palsy in children, who as preterm babies with suspected fetal compromise, were born immediately compared with those for whom birth was deferred (RR 5.88, 95% CI 1.33 to 26.02; one RCT; 507 children). Probably ineffective interventions: moderate-quality evidence of lack of effectiveness There was no clear difference in the presence of cerebral palsy in children born to women at risk of preterm birth who received repeat doses of corticosteroids compared with a single course (RR 1.03, 95% CI 0.71 to 1.50; four RCTs; 3800 children). No conclusions possible: low- to very low-quality evidence Low-quality evidence found there was a possible reduction in cerebral palsy for children born to women at risk of preterm birth who received antenatal corticosteroids for accelerating fetal lung maturation compared with placebo (RR 0.60, 95% CI 0.34 to 1.03; five RCTs; 904 children). There was no clear difference in the presence of cerebral palsy with interventionist care for severe pre-eclampsia versus expectant care (RR 6.01, 95% CI 0.75 to 48.14; one RCT; 262 children); magnesium sulphate for pre-eclampsia versus placebo (RR 0.34, 95% CI 0.09 to 1.26; one RCT; 2895 children); continuous cardiotocography for fetal assessment during labour versus intermittent auscultation (average RR 1.75, 95% CI 0.84 to 3.63; two RCTs; 13,252 children); prenatal progesterone for prevention of preterm birth versus placebo (RR 0.14, 95% CI 0.01 to 3.48; one RCT; 274 children); and betamimetics for inhibiting preterm labour versus placebo (RR 0.19, 95% CI 0.02 to 1.63; one RCT; 246 children).Very low-quality found no clear difference for the presence of cerebral palsy with any antihypertensive drug (oral beta-blockers) for treatment of mild to moderate hypertension versus placebo (RR 0.33, 95% CI 0.01 to 8.01; one RCT; 110 children); magnesium sulphate for prevention of preterm birth versus other tocolytic agents (RR 0.13, 95% CI 0.01 to 2.51; one RCT; 106 children); and vitamin K and phenobarbital prior to preterm birth for prevention of neonatal periventricular haemorrhage versus placebo (RR 0.77, 95% CI 0.33 to 1.76; one RCT; 299 children).

Authors' conclusions: This overview summarises evidence from Cochrane reviews on the effects of antenatal and intrapartum interventions on cerebral palsy, and can be used by researchers, funding bodies, policy makers, clinicians and consumers to aid decision-making and evidence translation. We recommend that readers consult the included Cochrane reviews to formally assess other benefits or harms of included interventions, including impacts on risk factors for cerebral palsy (such as the reduction in intraventricular haemorrhage for preterm babies following exposure to antenatal corticosteroids).Magnesium sulphate for women at risk of preterm birth for fetal neuroprotection can prevent cerebral palsy. Prophylactic antibiotics for women in preterm labour with intact membranes, and immediate rather than deferred birth of preterm babies with suspected fetal compromise, may increase the risk of cerebral palsy. Repeat doses compared with a single course of antenatal corticosteroids for women at risk of preterm birth do not clearly impact the risk of cerebral palsy.Cerebral palsy is rarely diagnosed at birth, has diverse risk factors and causes, and is diagnosed in approximately one in 500 children. To date, only a small proportion of Cochrane reviews assessing antenatal and intrapartum interventions have been able to report on this outcome. There is an urgent need for long-term follow-up of RCTs of interventions addressing risk factors for cerebral palsy, and consideration of the use of relatively new interim assessments (including the General Movements Assessment). Such RCTs must be rigorous in their design, and aim for consistency in cerebral palsy outcome measurement and reporting to facilitate pooling of data, to focus research efforts on prevention.

PubMed Disclaimer

Conflict of interest statement

The overview authors were authors of some of the Cochrane systematic reviews that were considered for inclusion in this review. Assessment of eligibility of any and all of these reviews, and where included, data collection and analysis (including quality assessment) for these reviews, was carried out by two overview authors not involved in the individual Cochrane reviews.

Emily Shepherd, Philippa Middleton, and Caroline Crowther are investigators on a Project Grant from the Cerebral Palsy Alliance Research Foundation, Australia, which supported the conduct of this overview.

Maria Makrides has served on scientific advisory boards for Nestle and Fonterra. Associated honoraria were paid to the Women's and Children's Health Research Institute to support conference travel and continuing education for postgraduate students and early career researchers.

Sarah McIntyre is employed by Cerebral Palsy Alliance and the University of Sydney. She has also been invited to a number of international meetings where travel costs have been paid by the organisers of the meeting, e.g. Surveillance of Cerebral Palsy Europe.

Rehana Salam: none know.

Nadia Badawi: none known.

Figures

1
1
Review flow diagram.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD012077

References

References to included reviews

Abalos 2014
    1. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD002252.pub3] - DOI - PubMed
Alfirevic 2013
    1. Alfirevic Z, Devane D, Gyte GML. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD006066.pub2] - DOI - PubMed
Churchill 2013
    1. Churchill D, Duley L, Thornton JG, Jones L. Interventionist versus expectant care for severe pre‐eclampsia between 24 and 34 weeks' gestation. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD003106.pub2] - DOI - PubMed
Crowther 2010
    1. Crowther CA, Crosby DD. Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD000229.pub2] - DOI - PMC - PubMed
Crowther 2010a
    1. Crowther CA, Crosby DD. Phenobarbital prior to preterm birth for preventing neonatal periventricular haemorrhage. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD000164.pub2] - DOI - PMC - PubMed
Crowther 2014
    1. Crowther CA, Brown J, McKinlay CJD, Middleton P. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI: 10.1002/14651858.CD001060.pub2] - DOI - PMC - PubMed
Crowther 2015
    1. Crowther CA, McKinlay CJD, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database of Systematic Reviews 2015, Issue 7. [DOI: 10.1002/14651858.CD003935.pub4] - DOI - PMC - PubMed
Dodd 2013
    1. Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD004947.pub3] - DOI - PMC - PubMed
Doyle 2009
    1. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD004661.pub3] - DOI - PubMed
Duley 2010
    1. Duley L, Gülmezoglu AM, Henderson‐Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre‐eclampsia. Cochrane Database of Systematic Reviews 2010, Issue 11. [DOI: 10.1002/14651858.CD000025.pub2] - DOI - PMC - PubMed
Flenady 2013
    1. Flenady V, Hawley G, Stock OM, Kenyon S, Badawi N. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database of Systematic Reviews 2013, Issue 12. [DOI: 10.1002/14651858.CD000246.pub2] - DOI - PMC - PubMed
Magee 2003
    1. Magee L, Duley L. Oral beta‐blockers for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD002863] - DOI - PubMed
Neilson 2014
    1. Neilson JP, West HM, Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD004352.pub3] - DOI - PMC - PubMed
Roberts 2006
    1. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004454.pub2] - DOI - PubMed
Stock 2016
    1. Stock SJ, Bricker L, Norman JE. Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes. Cochrane Database of Systematic Reviews 2016, Issue 7. [DOI: 10.1002/14651858.CD008968.pub3] - DOI - PMC - PubMed

References to excluded reviews

Abou El Senoun 2014
    1. Abou El Senoun G, Dowswell T, Mousa HA. Planned home versus hospital care for preterm prelabour rupture of the membranes (PPROM) prior to 37 weeks' gestation. Cochrane Database of Systematic Reviews 2014, Issue 4. [DOI: 10.1002/14651858.CD008053.pub3] - DOI - PMC - PubMed
Bricker 2015
    1. Bricker L, Medley N, Pratt JJ. Routine ultrasound in late pregnancy (after 24 weeks' gestation). Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD001451.pub4] - DOI - PMC - PubMed
Buchanan 2010
    1. Buchanan SL, Crowther CA, Levett KM, Middleton P, Morris J. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD004735.pub3] - DOI - PubMed
Chapman 2014
    1. Chapman E, Reveiz L, Illanes E, Bonfill Cosp X. Antibiotic regimens for management of intra‐amniotic infection. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD010976.pub2] - DOI - PMC - PubMed
Crowley 2016
    1. Crowley AE, Grivell RM, Dodd JM. Sealing procedures for preterm prelabour rupture of membranes. Cochrane Database of Systematic Reviews 2016, Issue 7. [DOI: 10.1002/14651858.CD010218.pub2] - DOI - PMC - PubMed
Dare 2006
    1. Dare MR, Middleton P, Crowther CA, Flenady V, Varatharaju B. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD005302.pub2] - DOI - PubMed
East 2014
    1. East CE, Begg L, Colditz PB, Lau R. Fetal pulse oximetry for fetal assessment in labour. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD004075.pub4] - DOI - PMC - PubMed
Gomi 2015
    1. Gomi H, Goto Y, Laopaiboon M, Usui R, Mori R. Routine blood cultures in the management of pyelonephritis in pregnancy for improving outcomes. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: 10.1002/14651858.CD009216.pub2] - DOI - PMC - PubMed
Han 2013
    1. Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD000940.pub3] - DOI - PMC - PubMed
Hofmeyr 2015
    1. Hofmeyr GJ, Barrett JF, Crowther CA. Planned caesarean section for women with a twin pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 12. [DOI: 10.1002/14651858.CD006553.pub3] - DOI - PMC - PubMed
Hopkins 2002
    1. Hopkins L, Smaill FM. Antibiotic regimens for management of intra‐amniotic infection. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003254] - DOI - PMC - PubMed
Kenyon 2013
    1. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database of Systematic Reviews 2013, Issue 12. [DOI: 10.1002/14651858.CD001058.pub3] - DOI - PMC - PubMed
Khunpradit 2011
    1. Khunpradit S, Lumbiganon P, Laopaiboon M. Admission tests other than cardiotocography for fetal assessment during labour. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD008410.pub2] - DOI - PMC - PubMed
Kiiza 2015
    1. Kiiza JAK, Hofmeyr GJ. Amnioinfusion for chorioamnionitis. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD011622] - DOI - PMC - PubMed
Lewin 2010
    1. Lewin S, Munabi‐Babigumira S, Glenton C, Daniels K, Bosch‐Capblanch X, Wyk BE, et al. Lay health workers in primary and community health care for maternal and child health and the management of infectious diseases. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD004015.pub3] - DOI - PMC - PubMed
Lutomski 2015
    1. Lutomski JE, Meaney S, Greene RA, Ryan AC, Devane D. Expert systems for fetal assessment in labour. Cochrane Database of Systematic Reviews 2015, Issue 4. [DOI: 10.1002/14651858.CD010708.pub2] - DOI
Mackeen 2014
    1. Mackeen AD, Seibel‐Seamon J, Muhammad J, Baxter JK, Berghella V. Tocolytics for preterm premature rupture of membranes. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD007062.pub3] - DOI - PMC - PubMed
Neilson 2003
    1. Neilson JP. Interventions for suspected placenta praevia. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD001998] - DOI - PubMed
Olsen 2012
    1. Olsen O, Clausen JA. Planned hospital birth versus planned home birth. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD000352.pub2] - DOI - PMC - PubMed
Othman 2007
    1. Othman M, Alfirevic Z, Neilson JP. Probiotics for preventing preterm labour. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD005941.pub2] - DOI - PMC - PubMed
Sangkomkamhang 2015
    1. Sangkomkamhang US, Lumbiganon P, Prasertcharoensuk W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: 10.1002/14651858.CD006178.pub3] - DOI - PMC - PubMed
Say 1996
    1. Say L, Gülmezoglu AM, Hofmeyr GJ. Transcutaneous electrostimulation for suspected placental insufficiency (diagnosed by Doppler studies). Cochrane Database of Systematic Reviews 1996, Issue 1. [DOI: 10.1002/14651858.CD000079] - DOI - PMC - PubMed
Say 1996a
    1. Say L, Gülmezoglu AM, Hofmeyr GJ. Plasma volume expansion for suspected impaired fetal growth. Cochrane Database of Systematic Reviews 1996, Issue 4. [DOI: 10.1002/14651858.CD000167] - DOI - PMC - PubMed
Say 1996b
    1. Say L, Gülmezoglu AM, Hofmeyr GJ. Calcium channel blockers for potential impaired fetal growth. Cochrane Database of Systematic Reviews 1996, Issue 1. [DOI: 10.1002/14651858.CD000049] - DOI - PMC - PubMed
Say 1996c
    1. Say L, Gülmezoglu AM, Hofmeyr GJ. Bed rest in hospital for suspected impaired fetal growth. Cochrane Database of Systematic Reviews 1996, Issue 1. [DOI: 10.1002/14651858.CD000034] - DOI - PMC - PubMed
Say 2001
    1. Say L, Gülmezoglu AM, Hofmeyr GJ. Betamimetics for suspected impaired fetal growth. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD000036] - DOI - PubMed
Say 2003
    1. Say L, Gülmezoglu AM, Hofmeyr GJ. Maternal oxygen administration for suspected impaired fetal growth. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD000137] - DOI - PubMed
Say 2003a
    1. Say L, Gülmezoglu AM, Hofmeyr GJ. Maternal nutrient supplementation for suspected impaired fetal growth. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD000148] - DOI - PubMed
Say 2003b
    1. Say L, Gülmezoglu AM, Hofmeyr GJ. Hormones for suspected impaired fetal growth. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD000109] - DOI - PubMed
Siegfried 2011
    1. Siegfried N, Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother‐to‐child transmission of HIV infection. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD003510.pub3] - DOI - PubMed
Siriwachirachai 2014
    1. Siriwachirachai T, Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Antibiotics for meconium‐stained amniotic fluid in labour for preventing maternal and neonatal infections. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD007772.pub3] - DOI - PMC - PubMed
Stan 2013
    1. Stan CM, Boulvain M, Pfister R, Hirsbrunner‐Almagbaly P. Hydration for treatment of preterm labour. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD003096.pub2] - DOI - PMC - PubMed
Thomas 2007
    1. Thomas JT, Muller P, Wilkinson CS. Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD005541.pub2] - DOI - PMC - PubMed

Additional references

Abdel‐Latif 2010
    1. Abdel‐Latif ME, Osborn DA, Challis D Cochrane Database of Systematic. Intra‐amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007916.pub2] - DOI - PMC - PubMed
Access Economics 2008
    1. Access Economics. The Economic Impact of Cerebral Palsy in Australia in 2007. Sydney: Cerebral Palsy Australia, 2008.
ACPR Group 2013
    1. Australian Cerebral Palsy Register (ACPR) Group. Report of the Australian Cerebral Palsy Register, Birth Years 1993–2006. Sydney: ACPR Group, 2013.
Amorim 2011
    1. Amorim MMR, Souza ASR, Katz L, Noronha Neto C. Planned caesarean section versus planned vaginal delivery for severe preeclampsia. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD009430] - DOI
Badawi 2013
    1. Badawi N, Keogh JM. Causal pathways in cerebral palsy. Journal of Paediatrics and Child Health 2013;49(1):5‐8. - PubMed
Bax 1964
    1. Bax MCO. Terminology and classification of cerebral palsy. Developmental Medicine & Child Neurology 1964;6(3):295‐7. - PubMed
Blair 1988
    1. Blair E, Stanley FJ. Intrapartum asphyxia: a rare cause of cerebral palsy. Journal of Pediatrics 1988;112(4):515‐9. - PubMed
Blair 2001
    1. Blair E, Watson L, Badawi N, Stanley FJ. Life expectancy among people with cerebral palsy in Western Australia. Developmental Medicine & Child Neurology 2001;43(8):508‐15. - PubMed
Blair 2006
    1. Blair E, Watson L. Epidemiology of cerebral palsy. Seminars in Fetal and Neonatal Medicine 2006;11:117‐25. - PubMed
Bosanquet 2013
    1. Bosanquet M, Copeland L, Ware R, Boyd R. A systematic review of tests to predict cerebral palsy in young children. Developmental Medicine and Child Neurology 2013;55(5):418‐26. - PubMed
Cans 2000
    1. Cans C. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Developmental Medicine & Child Neurology 2000;42(12):816‐24. - PubMed
CDC 2004
    1. Centers for Disease Control and Prevention (CDC). Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment ‐ United States, 2003. MMWR: Morbidity and Mortality Weekly Report 2004;53(3):57‐9. - PubMed
Chang 2015
    1. Chang E. Preterm birth and the role of neuroprotection. BMJ 2015;350:g6661. - PubMed
Colver 2012
    1. Colver A. Outcomes for people with cerebral palsy: life expectancy and quality of life. Paediatrics and Child Health 2012;22(9):384‐7.
Colver 2014
    1. Colver A, Fairhurst C, Pharoah PO. Cerebral palsy. Lancet 2014;383:1240‐9. - PubMed
Compagnone 2014
    1. Compagnone E, Maniglio J, Camposeo S, Vespino T, Losito L, Rinaldis M, et al. Functional classifications for cerebral palsy: correlations between the gross motor function classification system (GMFCS), the manual ability classification system (MACS) and the communication function classification system (CFCS). Research in Developmental Disabilities 2014;35(11):2651‐7. - PubMed
Covidence 2015 [Computer program]
    1. Veritas Health Innovation. Covidence. Version accessed 17 May 2015. Melbourne, Australia: Veritas Health Innovation, 2015.
Davis 2010
    1. Davis E, Shelley A, Waters E, Boyd R, Cook K, Davern M. The impact of caring for a child with cerebral palsy: quality of life for mothers and fathers. Child: Care, Health and Development 2010;36:63‐73. - PubMed
Eliasson 2006
    1. Eliasson AC, Krumlinde‐Sundholm L, Rösblad B, Beckung E, Arner M, Ohrvall AM, et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Developmental Medicine & Child Neurology 2006;48:549‐54. - PubMed
Ellenberg 2013
    1. Ellenberg JH, Nelson KB. The association of cerebral palsy with birth asphyxia: a definitional quagmire. Developmental Medicine & Child Neurology 2013;55:210‐6. - PubMed
Farquhar 2015
    1. Farquhar C, Rishworth JR, Brown J, Nelen WLDM, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database of Systematic Reviews 2015, Issue 7. [DOI: 10.1002/14651858.CD010537.pub4] - DOI - PubMed
GRADEpro GDT 2015 [Computer program]
    1. McMaster University (developed by Evidence Prime). GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
Hemming 2005
    1. Hemming K, Hutton JL, Colver A, Platt M‐J. Regional variation in survival of people with cerebral palsy in the United Kingdom. Pediatrics 2005;116(6):1383‐90. - PubMed
Hidecker 2011
    1. Hidecker MJC, Paneth N, Rosenbaum PL, Kent RD, Lillie J, Eulenberg JB, et al. Developing and validating the Communication Function Classification System for individuals with cerebral palsy. Developmental Medicine & Child Neurology 2011;53(8):704‐10. - PMC - PubMed
Hidecker 2012
    1. Hidecker MJ, Ho NT, Dodge N, Hurvitz EA, Slaughter J, Workinger MS, et al. Inter‐relationships of functional status in cerebral palsy: analyzing gross motor function, manual ability, and communication function classification systems in children. Developmental Medicine and Child Neurology 2012;54(8):737‐42. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
Himpens 2008
    1. Himpens E, Broeck C, Oostra A, Calders P, Vanhaesebrouck P. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta‐analytic review. Developmental Medicine and Child Neurology 2008;50:334‐40. - PubMed
Hines 2015
    1. Hines M, Swinburn K, McIntyre S, Novak I, Badawi N. Infants at risk of cerebral palsy: a systematic review of outcomes used in Cochrane studies of pregnancy, childbirth and neonatology. Journal of Maternal‐Fetal & Neonatal Medicine 2015;28(16):1871‐83. - PubMed
Howard 2005
    1. Howard J, Soo B, Graham HK, Boyd RN, Reid S, Lanigan A, et al. Cerebral palsy in Victoria: motor types, topography and gross motor function. Journal of Paediatrics and Child Health 2005;41(9‐10):479‐83. - PubMed
Iams 2008
    1. Iams JD, Romero R, Culhane JF, Goldenberg RL. Preterm birth 2 ‐ Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 2008;371(9607):164‐75. - PubMed
IMPACT for CP 2011
    1. IMPACT for Cerebral Palsy. 2011 Summit Report. Availale from impact.cerebralpalsy.org.au/activities/research‐summits/2011‐summit‐report/ (accessed 17 May 2015).
Inder 2000
    1. Inder TE, Volpe JJ. Mechanisms of perinatal brain injury. Seminars in Neonatology 2000;5:3‐16. - PubMed
Jacobs 2013
    1. Jacobs SE, Berg M, Hunt R, Tarnow‐Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD003311.pub3] - DOI - PMC - PubMed
Jacobsson 2004
    1. Jacobsson B, Hagberg G. Antenatal risk factors for cerebral palsy. Best Practice & Research. Clinical Obstetrics & Gynaecology 2004;18(3):425‐36. - PubMed
Jones 2012
    1. Jones L, Othman M, Dowswell T, Alfirevic Z, Gates S, Newburn M, et al. Pain management for women in labour: an overview of systematic reviews. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD009234.pub2] - DOI - PMC - PubMed
Kruse 2009
    1. Kruse M, Michelsen SI, Flachs EM, Brønnum‐Hansen H, Madsen M, Uldall P. Lifetime costs of cerebral palsy. Developmental Medicine & Child Neurology 2009;51(8):622‐8. - PubMed
Lagunju 2009
    1. Lagunju IA, Fatunde OJ. The child with cerebral palsy in a developing country ‐ diagnosis and beyond. Journal of Pediatric Neurology 2009;7:375‐9.
Larroque 2003
    1. Larroque B, Marret S, Ancel PY, Arnaud C, Marpeau L, Supernant K, et al. White matter damage and intraventricular hemorrhage in very preterm infants: the EPIPAGE study. Journal of Pediatrics 2003;143(4):477‐83. - PubMed
Lassi 2015
    1. Lassi ZS, Middleton PF, Crowther C, Bhutta ZA. Interventions to improve neonatal health and later survival: an overview of systematic reviews. EBioMedicine 2015;2(8):983‐98. - PMC - PubMed
MacLennan 2015
    1. MacLennan AH, Thompson SC, Gecz J. Cerebral palsy: causes, pathways, and the role of genetic variants. American Journal of Obstetrics and Gynecology 2015;213(6):779‐88. - PubMed
McIntyre 2010
    1. McIntyre S, Novak I, Cusick A. Consensus research priorities for cerebral palsy: a Delphi survey of consumers, researchers, and clinicians. Developmental Medicine and Child Neurology 2010;52(3):270‐5. - PubMed
McIntyre 2011
    1. McIntyre S, Morgan C, Walker K, Novak I. Cerebral palsy ‐ don't delay. Developmental Disabilities Research Reviews 2011;17(2):114‐29. - PubMed
McIntyre 2013
    1. McIntyre S, Taitz D, Keogh J, Goldsmith S, Badawi N, Blair E. A systematic review of risk factors for cerebral palsy in children born at term in developed countries. Developmental Medicine and Child Neurology 2013;55:499‐508. - PubMed
Moreno‐De‐Luca 2012
    1. Moreno‐De‐Luca A, Ledbetter DH, Martin CL. Genetic insights into the causes and classification of cerebral palsies. Lancet Neurology 2012;11(3):283‐92. - PMC - PubMed
Morgan 2016
    1. Morgan C, Crowle C, Goyen T‐A, Hardman C, Jackman M, Novak I, et al. Sensitivity and specificity of General Movements Assessment for diagnostic accuracy of detecting cerebral palsy early in an Australian context. Journal of Paediatrics and Child Health 2016;52(1):54‐9. - PubMed
Morris 2004
    1. Morris C, Bartlett D. Gross Motor Function Classification System: impact and utility. Developmental Medicine & Child Neurology 2004;46:60‐5. - PubMed
Morris 2007
    1. Morris C. Definition and classification of cerebral palsy: a historical perspective. Developmental Medicine & Child Neurology 2007;49:3‐7. - PubMed
Mutch 1992
    1. Mutch L, Alberman E, Hagberg B, Kodama K, Perat MV. Cerebral palsy epidemiology: where are we now and where are we going?. Developmental Medicine & Child Neurology 1992;34(6):547‐51. - PubMed
Nelson 2008
    1. Nelson KB, Chang T. Is cerebral palsy preventable?. Current Opinion in Neurology 2008;21(2):129‐35. - PubMed
Nelson 2008b
    1. Nelson KB. Causative factors in cerebral palsy. Clinical Obstetrics and Gynecology 2008;51(4):749‐62. - PubMed
Novak 2012
    1. Novak I, Hines M, Goldsmith S, Barclay R. Clinical prognostic messages from a systematic review of cerebral palsy. Paediatrics 2012;130(5):e1285‐e1312. - PubMed
Oskoui 2013
    1. Oskoui M, Coutinho F, Dykeman J, Jetté N, Pringsheim T. An update on the prevalence of cerebral palsy: a systematic review and meta‐analysis. Developmental Medicine & Child Neurology 2013;55(6):509‐19. - PubMed
Oskoui 2015
    1. Oskoui M, Gazzellone MJ, Thiruvahindrapuram B, Zarrei M, Andersen J, Wei J. Clinically relevant copy number variations detected in cerebral palsy. Nature Communications 2015;6:7949. - PMC - PubMed
O’Callaghan 2009
    1. O’Callaghan ME, MacLennan AH, Haan EA, Dekker G, South Australian Cerebral Palsy Research Group. The genomic basis of cerebral palsy: a HuGE systematic literature review. Human Genetics 2009;126(1):149‐72. - PubMed
O’Shea 2008
    1. O’Shea MT. Diagnosis, treatment and prevention of cerebral palsy in near‐term/term infants. Clinical Obstetrics and Gynaecology 2008;51(4):816‐28. - PMC - PubMed
Palisano 1997
    1. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine & Child Neurology 1997;39(4):214‐23. - PubMed
Reid 2012
    1. Reid SM, Carlin JB, Reddihough DS. Survival of individuals with cerebral palsy born in Victoria, Australia, between 1970 and 2004. Developmental Medicine & Child Neurology 2012;54(4):353‐60. - PubMed
Reid 2016
    1. Reid SM, Meehan E, McIntyre S, Goldsmith S, Badawi N, Reddihough DS, the Australian Cerebral Palsy Register Group. Temporal trends in cerebral palsy by impairment severity and birth gestation. Developmental Medicine and Child Neurology 2016;58(Suppl 2):25‐35. - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Roberts 2017
    1. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2017, Issue 3. [DOI: 10.1002/14651858.CD004454.pub3] - DOI - PMC - PubMed
Robertson 2012
    1. Robertson NJ, Tan S, Groenendaal F, Bel F, Juul SE, Bennet L, et al. Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?. Journal of Pediatrics 2012;160:544‐52. - PMC - PubMed
Rosenbaum 2007
    1. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et al. A report: the definition and classification of cerebral palsy April 2006. Developmental Medicine and Child Neurology Supplement 2007;109:8‐14. - PubMed
Saliba 2001
    1. Saliba E, Marret S. Cerebral white matter damage in the preterm infant: pathophysiology and risk factors. Seminars in Neonatology 2001;6(2):121‐33. - PubMed
Sanger 2003
    1. Sanger TD, Delgado MR, Gaebler‐Spira D, Hallett M, Mink JW, Task Force on Childhood Motor Disorders. Classification and definition of disorders causing hypertonia in childhood. Pediatrics 2003;111(1):e89‐97. - PubMed
Sankar 2005
    1. Sankar C, Mundkur N. Cerebral palsy‐definition, classification, etiology and early diagnosis. Indian Journal of Pediatrics 2005;72(10):865‐8. - PubMed
Schünemann 2013
    1. Schünemann H, Brożek J, Guyatt G, Oxman A (editors). GRADE Handbook. The GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.
Sellier 2015
    1. Sellier E, Platt MJ, Andersen GL, Krägeloh‐Mann I, Cruz J, Cans C, et al. Decreasing prevalence in cerebral palsy: a multi‐site European population‐based study, 1980 to 2003. Developmental Medicine and Child Neurology 2015;58:85‐92. - PubMed
Shea 2009
    1. Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansoon E, Grimshaw J, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. Journal of Clinical Epidemiology 2009;62(10):1013‐20. - PubMed
Shepherd 2016
    1. Shepherd E, Middleton P, Makrides M, McIntyre SJ, Badawi N, Crowther CA. Neonatal interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews 2016, Issue 10. [DOI: 10.1002/14651858.CD012409] - DOI - PMC - PubMed
Smithers‐Sheedy 2014
    1. Smithers‐Sheedy H, Badawi N, Blair E, Cans C, Himmelmann K, Krägeloh‐Mann I, et al. What constitutes cerebral palsy in the twenty‐first century?. Developmental Medicine and Child Neurology 2014;56:323‐8. - PubMed
Strauss 2008
    1. Strauss D, Brooks J, Rosenbloom L, Shavelle R. Life expectancy in cerebral palsy: an update. Developmental Medicine & Child Neurology 2008;50(7):487‐93. - PubMed
Vexler 2001
    1. Vexler ZS, Ferriero DM. Molecular and biochemical mechanisms of perinatal brain injury. Seminars in Neonatology 2011;6:99‐108. - PubMed
Volpe 2000
    1. Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. Mental Retardation and Developmental Disabilities Research Reviews 2000;7:56‐64. - PubMed
Whiting 2014
    1. Whiting P, Savovic J, Higgins J, Shea B, Reeves B, Caldwell D, et al. ROBIS: a new tool to assess the risk of bias in a systematic review. Cochrane Colloquium. 2014 September 21‐16; Hyderabad. Hyderabad, India: Cochrane Collaboration. Available from colloquium.cochrane.org/abstracts/robis‐new‐tool‐assess‐risk‐bias‐system..., 2014.
WHO 2015
    1. World Health Organization (WHO). WHO recommendations on interventions to improve preterm birth outcomes. Available from who.int/reproductivehealth/publications/maternal_perinatal_health/preter... 2015; Vol. (accessed 20 August 2016).
Wood 2000
    1. Wood E, Rosenbaum P. The gross motor function classification system for cerebral palsy: a study of reliability and stability over time. Developmental Medicine & Child Neurology 2000;42:292‐6. - PubMed

Publication types